Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Buruli Ulcer Arwen Frick-Cheng Bio 402 What is Buruli Ulcer? • Infectious disease • Characterized by the WHO as a Neglected Tropical Diseases (NTD) ▫ 14 NTD ▫ Widely disregarded by industrial nations What is Buruli Ulcer? Regions/People Affected • Tropical wetlands and rainforest ▫ Mainly: West and Central Africa • • • • Associated with bodies of stagnant water The immunocompromised The poor Children Causative Agent • Mycobacterium ulcerans • Related to Tuberculosis, Leprosy Colonies of Mycobacterium ulcerans. http://www.public.asu.edu/~shaydel/research_002buruli.html Identification of Bacteria • • • • Acid Fast Stain Selective Culture Histopathology PCR Acid-fast stain of Mycobacterium ulcerans. http://www.who.int/buruli/information/diagnosis/en/index14.html Symptoms • Long latent period • Usually on exposed body parts • Four stages Virulence Factor • Toxin: Mycolactone ▫ Immunosupressant ▫ Necrosis Treatment • Antibiotic ▫ Rifampicin • Surgical removal/amputation • Vaccination (BCG) • Alternatives ▫ Heat treatment ▫ French Clay ▫ Topical nitrogen oxides • Will slowly heal on its own Effects • Heavy scarring ▫ Contracture of limbs ▫ Blindness • secondary infections References • Neglected Diseases Caused By Bacterial Infections. M. Bechtle, S. Chen and T. Efferth. Current Medicinal Chemistry, 2010, 17, 42-60 • Laboratory diagnosis of Buruli ulcer disease. Marcus Beissner, Karl-Heinz Herbinger & Gisela Bretzel . Future Science Group • Mycolactone Inhibits Monocyte Cytokine Production by a Posttranscriptional Mechanism. Rachel E. Simmonds et al. J. Immunol. 2009;182;2194-2202